Oral neostigmine and lymphatic absorption in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD)
Chan, P.C.; Tam, S.C.; Cheng, I.K.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 10(1): 93-96
1990
ISSN/ISBN: 0896-8608 PMID: 2085592 Document Number: 352635
The effects of oral neostigmine on peritoneal lymph absorption and transcapillary and net ultrafiltration were studied in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD). Oral neostigmine decreased lymphatic absorption, but only up to a threshold dose. The effect on net ultrafiltration however was nullified to some extent by a concurrent decrease in cumulative transcapillary ultrafiltration.